A Prospective Study With Induction Dosing Period Followed by a Maintenance Dosing Period to Evaluate the Efficacy and Safety of Etanercept (Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis

Status: Recruiting
Location: See all (40) locations...
Study Type: Observational
SUMMARY

This is a prospective, open-label, one-arm study. The study aims to assess the efficacy and safety of Etanercept therapy which help guide the clinical practice in real-world settings.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
View:

• 18 to 75 years of age 2.Moderate to severe chronic psoriasis, BSA≥3% 3.Duration of psoriasis≥6 months 4.Patients must be candidate for systemic therapy or phototherapy 5.No contradiction to Etanercept 6.Informed consent must be obtained 7.For female, ß-hCG test is negative and contraception is accepted

Locations
Other Locations
China
2nd Affiliated Hospital, School of Medicine, Zhejiang University
RECRUITING
Hangzhou
First Affiliated Hospital, Zhejiang Medical University
RECRUITING
Hangzhou
Hang Zhou First People's Hospital
RECRUITING
Hangzhou
Hang Zhou Third People's Hospital
RECRUITING
Hangzhou
Hospital of dermatology of Xiaoshan
RECRUITING
Hangzhou
Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University
RECRUITING
Hangzhou
the People Hospital of Zhejiang Province
RECRUITING
Hangzhou
Xiaoshan Hospital
RECRUITING
Hangzhou
Yuhang Fifth People's Hospital
RECRUITING
Hangzhou
Zhejiang Hospital of Traditional Chinese Medicine
RECRUITING
Hangzhou
Changxing Dermatology Hospital prevention and Treatment
RECRUITING
Huzhou
Chinese 72 Hospital
RECRUITING
Huzhou
Hospital of dermatology of Zhejiang Province
RECRUITING
Huzhou
Huzhou Central Hospital
RECRUITING
Huzhou
Huzhou First Hospital
RECRUITING
Huzhou
the People Hospital of Changxing
RECRUITING
Huzhou
Jiaxing First Hospital
RECRUITING
Jiaxing
Rongjun Hospital of Zhejiang Province
RECRUITING
Jiaxing
Tongxiang Dermatology Hospital prevention and Treatment
RECRUITING
Jiaxing
Hospital of dermatology of Yiwu
RECRUITING
Jinhua
Jinhua Central Hospital
RECRUITING
Jinhua
Jinhua Fifth Hospital
RECRUITING
Jinhua
the People Hospital of Dongyang
RECRUITING
Jinhua
Lishui Central Hospital
RECRUITING
Lishui
the People Hospital of Lishui
RECRUITING
Lishui
Ningbo Chinese Medical Hospital
RECRUITING
Ningbo
Ningbo First Hospital
RECRUITING
Ningbo
Ningbo Sixth Hospital
RECRUITING
Ningbo
Quzhou Chinese Medical Hospital
RECRUITING
Quzhou
the People Hospital of Quzhou
RECRUITING
Quzhou
Shangyu of Chinese Medical Hospital
RECRUITING
Shaoxing
Shaoxing Central Hospital
RECRUITING
Shaoxing
Shaoxing Third Hospital
RECRUITING
Shaoxing
the People Hospital of Shaoxing
RECRUITING
Shaoxing
Taizhou Central Hospital
RECRUITING
Taizhou
Wenling Chinese Medical Hospital
RECRUITING
Taizhou
the First Affiliated Hospital of Wenzhou medical university
RECRUITING
Wenzhou
the People Hospital of Cangnan
RECRUITING
Wenzhou
Wenzhou Chinese Medical Hospital
RECRUITING
Wenzhou
Wenzhou Combinational Hospital of Chinese and Western Medicine
RECRUITING
Wenzhou
Contact Information
Primary
Xiao-yong Man
manxy@zju.edu.cn
13600516219
Time Frame
Start Date: 2020-12-04
Estimated Completion Date: 2025-12-04
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: Second Affiliated Hospital, School of Medicine, Zhejiang University

This content was sourced from clinicaltrials.gov